| Residual embryonic cells as precursors of a Barrett's-like metaplasia X Wang, H Ouyang, Y Yamamoto, PA Kumar, TS Wei, R Dagher, ... Cell 145 (7), 1023-1035, 2011 | 393 | 2011 |
| The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors JR Strosberg, TR Halfdanarson, AM Bellizzi, JA Chan, JS Dillon, ... Pancreas 46 (6), 707-714, 2017 | 291 | 2017 |
| Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases O Basturk, L Tang, RH Hruban, V Adsay, Z Yang, AM Krasinskas, ... The American journal of surgical pathology 38 (4), 437-447, 2014 | 259 | 2014 |
| Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus SJ Rodig, J Cheng, J Wardzala, A DoRosario, JJ Scanlon, AC Laga, ... The Journal of clinical investigation 122 (12), 4645-4653, 2012 | 250 | 2012 |
| Colorectal cancer due to deficiency in DNA mismatch repair function: a review AM Bellizzi, WL Frankel Advances in anatomic pathology 16 (6), 405-417, 2009 | 208 | 2009 |
| NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract EB Stelow, AM Bellizzi, K Taneja, SE Mills, RD LeGallo, JL Kutok, ... The American journal of surgical pathology 32 (6), 828-834, 2008 | 206 | 2008 |
| Examination of low ERBB2 protein expression in breast cancer tissue AI Fernandez, M Liu, A Bellizzi, J Brock, O Fadare, K Hanley, M Harigopal, ... JAMA oncology 8 (4), 607-610, 2022 | 182 | 2022 |
| Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy? JE Maxwell, SK Sherman, TM O'Dorisio, AM Bellizzi, JR Howe Surgery 159 (1), 320-335, 2016 | 178 | 2016 |
| Mapping the immune environment in clear cell renal carcinoma by single-cell genomics N Borcherding, A Vishwakarma, AP Voigt, A Bellizzi, J Kaplan, K Nepple, ... Communications biology 4 (1), 122, 2021 | 173 | 2021 |
| Barbed suture for gastrointestinal closure: a randomized control trial SV Demyttenaere, P Nau, M Henn, C Beck, J Zaruby, M Primavera, ... Surgical innovation 16 (3), 237-242, 2009 | 171 | 2009 |
| The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical … PI Gonzalez‐Ericsson, ES Stovgaard, LF Sua, E Reisenbichler, Z Kos, ... The Journal of pathology 250 (5), 667-684, 2020 | 165 | 2020 |
| A novel SS18-SSX fusion-specific antibody for the diagnosis of synovial sarcoma E Baranov, MJ McBride, AM Bellizzi, AH Ligon, CDM Fletcher, C Kadoch, ... The American journal of surgical pathology 44 (7), 922-933, 2020 | 138 | 2020 |
| Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? AM Bellizzi Human pathology 96, 8-33, 2020 | 135 | 2020 |
| Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer Z Kos, E Roblin, RS Kim, S Michiels, BD Gallas, W Chen, KK van de Vijver, ... NPJ breast cancer 6 (1), 17, 2020 | 130 | 2020 |
| The North American neuroendocrine tumor society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors TR Halfdanarson, JR Strosberg, L Tang, AM Bellizzi, EK Bergsland, ... Pancreas 49 (7), 863-881, 2020 | 128 | 2020 |
| Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry AM Bellizzi Advances in anatomic pathology 20 (5), 285-314, 2013 | 123 | 2013 |
| Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group M Amgad, ES Stovgaard, E Balslev, J Thagaard, W Chen, S Dudgeon, ... NPJ breast cancer 6 (1), 16, 2020 | 119 | 2020 |
| Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer ES Reisenbichler, G Han, A Bellizzi, V Bossuyt, J Brock, K Cole, O Fadare, ... Modern pathology 33 (9), 1746-1752, 2020 | 107 | 2020 |
| Pancreatic cytopathology: a practical approach and review AM Bellizzi, EB Stelow Archives of pathology & laboratory medicine 133 (3), 388-404, 2009 | 93 | 2009 |
| An algorithmic immunohistochemical approach to define tumor type and assign site of origin AM Bellizzi Advances in anatomic pathology 27 (3), 114-163, 2020 | 81 | 2020 |
Jason L. HornickProfessor of Pathology, Harvard Medical SchoolVerified email at partners.org
